Delivery Order SPE2DB22D1017-SPE2DB25FF3NT
Award Date
1/21/25
Potential Completion Date
2/11/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Moderna COVID-19 vaccine doses for 6-month to 11-year-old recipients under the Emergency Use Authorization (EUA). The fixed-price delivery order, valued at $1,302.54, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC enables efficient...
This federal contract award, valued at $2,215.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract, valued at $1,290.00, is a firm fixed-price delivery order contract with a completion date of March 12, 2025. The contract does not have a set-aside designation. Amerisourcebergen...
This federal contract award, valued at $16,888.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25mL doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The award has an ultimate completion date of October 20, 2023. This contract is a delivery order with a firm fixed-price...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Moderna COVID-19 vaccines for the 6 month to 11 year old age group under the Emergency Use Authorization (EUA). The contract is a firm fixed-price delivery order with a ceiling value of $1,290.00 and a period of performance through March 13, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $1,290.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years old under an Emergency Use Authorization (EUA). The contract is a $4,752.75 firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, has an award value of $1,272.22 and is for the delivery of 0.25 ml doses of the Moderna COVID-19 vaccine to support the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract is a Delivery Order under a Firm Fixed Price arrangement and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This award is not a set-aside contract. The contract has an ultimate...
This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This is a firm-fixed-price contract with a completion date of November 13, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government...